Systematic review and meta-analysis of budesonide/formoterol in a single inhaler
SJ Edwards, K Gruffydd-Jones… - Current medical research …, 2007 - Taylor & Francis
Objective: To compare the effectiveness of budesonide/formoterol using fixed dosing
(BUD/FORM) with inhaled corticosteroid (ICS) alone or alternative ICS and long-acting β2 …
(BUD/FORM) with inhaled corticosteroid (ICS) alone or alternative ICS and long-acting β2 …
Budesonide: safety and efficacy aspects of its long‐term use in children
LB Ribeiro - Pediatric Allergy and Immunology, 1993 - Wiley Online Library
Fifty‐two asthmatic children aged 4 to 13 years (mean 9. 6) were enrolled in this open 12‐
month study of budesonide, 200 meg bid, administered by tube‐spacer inhaler (INHALETE® …
month study of budesonide, 200 meg bid, administered by tube‐spacer inhaler (INHALETE® …
Review of the unique properties of budesonide
EJ O'Connell - Clinical therapeutics, 2003 - Elsevier
Background: The aim of inhaled corticosteroid (ICS) therapy for asthma is to attain high
therapeutic activity in the airways while keeping the risk of systemic adverse effects relatively …
therapeutic activity in the airways while keeping the risk of systemic adverse effects relatively …
Once versus twice daily budesonide metered-dose inhaler in children with mild to moderate asthma: effect on symptoms and bronchial responsiveness
J Mallol, V Aguirre - Allergologia et immunopathologia, 2007 - Elsevier
BACKGROUND: Simplifying dosing regimens could improve both adherence and asthma-
related morbidity. However, there is little information on the effectiveness of once-daily …
related morbidity. However, there is little information on the effectiveness of once-daily …
Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma
UG Lalloo, J Malolepszy, D Kozma, K Krofta, J Ankerst… - Chest, 2003 - Elsevier
Background: We evaluated the efficacy and safety of low-dose budesonide/formoterol, 80
μg/4.5 μg, bid in a single inhaler (Symbicort Turbuhaler; AstraZeneca; Lund, Sweden) …
μg/4.5 μg, bid in a single inhaler (Symbicort Turbuhaler; AstraZeneca; Lund, Sweden) …
[HTML][HTML] Effect of disease duration on dose–response of inhaled budesonide in asthma
O Selroos - Respiratory medicine, 2008 - Elsevier
BACKGROUND: Inhaled corticosteroids (ICS) represent first-line treatment in persistent
asthma with clinical studies showing benefits of initiating therapy early. Whether treatment …
asthma with clinical studies showing benefits of initiating therapy early. Whether treatment …
Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma
A Tal, G Simon, JH Vermeulen, V Petru… - Pediatric …, 2002 - Wiley Online Library
The aim of this study was to evaluate the efficacy (expressed as effect on lung function) and
tolerability of Symbicort®(budesonide/formoterol in a single inhaler) in children with asthma …
tolerability of Symbicort®(budesonide/formoterol in a single inhaler) in children with asthma …
Budesonide inhalation suspension: a nebulized corticosteroid for persistent asthma
SJ Szefler, H Eigen - Journal of Allergy and Clinical Immunology, 2002 - Elsevier
Guidelines for managing asthma in pediatric patients published by the American Academy
of Allergy, Asthma, and Immunology and the American Academy of Pediatrics recommend …
of Allergy, Asthma, and Immunology and the American Academy of Pediatrics recommend …
Once‐daily budesonide: 400 μg once daily is as effective as 200 μg twice daily in controlling childhood asthma
LM Campbell, B Bodalia… - … journal of clinical …, 1998 - Wiley Online Library
One hundred and sixty seven children on 0‐200 μg/day of inhaled steroid with asthma
symptoms and sub‐optimal peak flow values (less than 90% of that predicted for their …
symptoms and sub‐optimal peak flow values (less than 90% of that predicted for their …
Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised …
M Noonan, LJ Rosenwasser, P Martin, CD O'Brien… - Drugs, 2006 - Springer
Abstract Background: Inhaled corticosteroids (ICSs) are the preferred maintenance therapy
for adults and children with mild, moderate and severe persistent asthma, with the addition …
for adults and children with mild, moderate and severe persistent asthma, with the addition …